Resources

The relationship between pathogenic factors and beta-cell destruction remains poorly understood. Longitudinal studies of newborns and children at genetic risk and follow-up of at-risk first-degree relatives in natural history studies link the triggering of autoimmunity with the appearance of autoantibodies to one or more islet autoantigens; individuals with multiple autoantibodies have higher risk of diabetes progression.

In this Exclusive Interview transcript, Lisa Latts talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about applications of Watson AI for diabetes care and the benefits for healthcare providers and patients who have diabetes and are taking diabetes medications.

In this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about Watson AI and what it can offer to healthcare providers and patients who have diabetes and are taking diabetes medications.

In part 1 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the work done in partnership with the ADA regarding findings among patients with diabetes and their use of medications.

In part 2 of this Exclusive Interview, Lisa Latts explains the process behind the artificial intelligence Watson in a conversation with Diabetes in Control Publisher Steve Freed.

In part 3 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the personalization of medicine as the future of diabetes care.

In part 4 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the genesis of Watson and the work currently in the pipeline.

In part 5 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the findings from the cardiovascular study for use in Watson.

In part 6 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about her desire to make the healthcare system work more effectively and improve the practice of medicine.

In part 7, the conclusion of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the Watson tools available and how to access them.